New Key Statistics Module, Z-Score and F-Score
NAS:CASI Key Ratios
| Market Cap $ M | 37.46 |
| Enterprise Value $ M | 27.93 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.55 |
| Price/Sales | 1.10 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 33.00 |
| EPS (TTM) $ | -2.03 |
| Beneish M-Score | -5.02 |
| 10-y EBITDA Growth Rate % | 5.20 |
| 5-y EBITDA Growth Rate % | 14.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.10 |
| EV-to-EBITDA | -1.10 |
| PEG | -- |
| Shares Outstanding M | 13.40 |
| Net Margin (%) | -79.51 |
| Operating Margin % | -74.62 |
| Pre-tax Margin (%) | -77.61 |
| Quick Ratio | 2.60 |
| Current Ratio | 3.55 |
| ROA % (ttm) | -32.69 |
| ROE % (ttm) | -79.54 |
| ROIC % (ttm) | -86.03 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.87 |
CASI Number of Guru Trades
CASI Volume of Guru Trades
Gurus Latest Trades with NAS:CASI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CASI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CASI Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CASI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers